The SEC declared effective on July 27, 2026, an S-1 registration statement filed by Propanc Biopharma, Inc. (NASDAQ: PPCB) covering 2,500,000 shares of common stock for resale by a single selling stockholder, Hexstone Capital. That block represents roughly 71% of the company's 3.5 million shares currently outstanding. Hexstone can begin selling immediately, at its discretion.
What the Filing Covers
The registered shares stem from a $1 million private placement — a sale negotiated directly with an investor rather than offered on the open market — in which Propanc issued Series C Preferred Stock to Hexstone. Each preferred share converts into common stock at the lesser of a fixed $125.00 per share or 85% of the lowest trading price over a variable, volume-weighted measuring period. That pricing mechanism is commonly called a "death-spiral" convertible — meaning the lower the stock trades, the more common shares each preferred share converts into, which in turn can push the price lower still.
The 2,500,000 shares registered now may therefore understate the ultimate share count. Propanc has agreed to reserve 9.5 million shares of common stock — roughly 200% of the initially registered amount — to cover potential future conversions.
Warrant Overhang
The deal also includes a warrant granting Hexstone the right to acquire an additional 9,700 Series C Preferred shares with $99 million in aggregate face value. Any exercise and subsequent conversion would generate still more common shares. The filing discloses a $12.50 per-share floor price on conversions, but the board retains the authority to adjust that floor downward. Seven structural red flags are present in the filing: variable pricing, a deep discount to market, a short VWAP — volume-weighted average price — measuring window, reset provisions, weighted-average anti-dilution protection, and the effective absence of a hard floor.
Recent Corporate Context
Propanc completed a 1-for-25 reverse stock split in May 2026 when the stock was trading near $1.63. Reverse splits reduce the share count and raise the per-share price, often to maintain exchange listing standards. The variable-rate convertible was issued shortly afterward. The company also reports approximately $212,000 in defaulted debt obligations and carries an accumulated deficit of $140.8 million.
What to Watch
Because this is a resale registration — not a primary offering — there will be no 424B5 pricing supplement or public takedown announcement. Hexstone's sales, if any, will appear only in subsequent beneficial-ownership filings and quarterly reports. The registered supply can reach the open market as early as July 27, 2026, and the pace will depend entirely on Hexstone's discretion, market conditions, and the rate at which it converts preferred shares into common stock.